Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Total Liabilities 2013–2025
Zevra Therapeutics, Inc. annual total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Zevra Therapeutics, Inc. total liabilities as of December 31, 2025: 130.1M, a 6.06% decrease year-over-year.
- Zevra Therapeutics, Inc. total liabilities for 2025 were 130.1M, a 6.06% decrease from 2024.
- Zevra Therapeutics, Inc. total liabilities for 2024 were 138.5M, a 25.35% increase from 2023.
- Zevra Therapeutics, Inc. total liabilities for 2023 were 110.5M, a 174.65% increase from 2022.
- Zevra Therapeutics, Inc. total liabilities for 2022 were 40.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Zevra Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $130 |
| 2024 | $138 |
| 2023 | $110 |
| 2022 | $40 |
| 2021 | $6 |
| 2020 | $78 |
| 2019 | $85 |
| 2018 | $93 |
| 2015 | $65 |
| 2014 | $38 |
Zevra Therapeutics, Inc. Total Liabilities — FAQ
Zevra Therapeutics, Inc. (ZVRA) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZVRA's total liabilities history?
The chart and table above show Zevra Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.